To effectively address this, EQUIP has embarked on a demonstration project which seeks to evaluate the cost and treatment outcomes of a simplified model for Hepatitis C Virus (HCV) testing, treatment, and care which is integrated with HIV testing and treatment. This demonstration project aims to improve access to HCV treatment and enhance ART initiation and adherence for the most-at-risk HIV/HCV co-infected populations.
Myanmar (formerly Burma) has embarked on what will be a long and challenging road of democratic and economic reform. Political reforms that started in 2011 have set in motion critical transitions in Burma: moving toward an inclusive, parliamentary democracy; negotiating ceasefires after decades-long civil wars; and shifting to a market-oriented economy.
Burma’s population faces formidable obstacles to realizing healthy, productive lives. A quarter of the country lives in poverty. Over 600,000 people remain internally displaced by decades of conflict. HIV, drug-resistant malaria and tuberculosis and malnutrition rates are among the region’s highest. A lack of trained health professionals and medical supply chains hinder an already weak health system. What limited investments are made in social services are often undermined by natural disasters and ethnic conflicts.